| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000002097 |
| Receipt No. | R000002534 |
| Official scientific title of the study | Evaluation of accuracy of computed tomographic colonography (CTC) in the diagnosis of colorectal tumor by gastroenterologists and radiologists with computer-aided detection (CAD): A multicenter study |
| Date of disclosure of the study information | 2009/06/20 |
| Last modified on | 2016/11/07 (Ver. 16) |
| Basic information | ||
| Official scientific title of the study | Evaluation of accuracy of computed tomographic colonography (CTC) in the diagnosis of colorectal tumor by gastroenterologists and radiologists with
computer-aided detection (CAD): A multicenter study |
|
| Title of the study (Brief title) | Japanese National CT Colonography Trial | |
| Region |
|
|
| Condition | ||||
| Condition | colorectal cancer, colorectal polyp | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To address the accuracy of CT colonography (CTC) in detecting colorectal polyps and cancers in subjects at increased risk of colorectal cancer, using optical colonoscopy as the reference standard. This clinical study will also evaluate the differences of the detection accuracies between human readings with and without computer-aided detection (CAD). In addition, this study will compare diagnostic performance between radiologists and gastroenterologists. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | CTC vs. optical colonoscopy. Detection performance and accuracy of colorectal polyps (at least 6 mm in diameter) and colorectal cancer. |
| Key secondary outcomes | The differences of detection performance of human readings without and with CAD.
Diagnostic performances between radiologists and gastroenterologists. Comparative adherence of patients to CTC and optical colonoscopy. Frequency and nature of any adverse events. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | CTC and optical colonoscopy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Outpatients who are eligible for optical colonoscopy.
2) Aged 20 years or older. 3) Major functions of organs of the subjects are in a good condition. 4) Signed informed consent forms are obtained by the patients. |
|||
| Key exclusion criteria | 1) Known colorectal polyps or cancers at any site at the time of enrollment.
2) Patients with inflammatory bowel disease. 3) Fulfillment of clinical criteria for diagnosis of FAP or HNPCC (Amsterdam criteria). 4) Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit. 5) Previous colorectal surgery. 6) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon. 7) Evidence of an increased risk in carrying out bowel preparation or CTC exams. 8) Possibility of pregnancy. 9) Optical colonoscopy or barium enema carried out within the last 3 years. 10) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial. 11) Iodine hypersensitivity. 12) Severe thyroid disease. 13) Claustrophobia. 14) Severe deafness. 15) Subjects whose eligibility for this clinical trial is not appropriate by other reasons. |
|||
| Target sample size | 1500 | |||
| Research contact person | |
| Name of lead principal investigator | Koichi Nagata |
| Organization | Massachusetts General Hospital and Harvard Medical School |
| Division name | 3D Imaging Laboratory, Department of Radiology |
| Address | 25 New Chardon St., Suite 400C, Boston, MA 02114, USA |
| TEL | +1-617-643-4321 |
| ctc_trial@live.jp | |
| Public contact | |
| Name of contact person | Koichi Nagata |
| Organization | Massachusetts General Hospital and Harvard Medical School |
| Division name | 3D Imaging Laboratory, Department of Radiology |
| Address | 25 New Chardon St., Suite 400C, Boston, MA 02114, USA |
| TEL | +1-617-643-4321 |
| Homepage URL | |
| ctc_trial@live.jp | |
| Sponsor | |
| Institute | Japanese CTC Society |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto Co., Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Showa University Northern Yokohama Hospital |
| Name of secondary funder(s) | Aze, Ltd.
Horii Pharmaceutical Ind., Ltd. CancerScan Co., Ltd. |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | NCT00997802 |
| Org. issuing International ID_1 | ClinicalTrials.gov |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 北海道社会事業協会小樽病院(北海道)、北海道消化器科病院(北海道)、北海道社会保険病院(北海道)、秋田赤十字病院(秋田県)、自治医科大学附属病院(栃木県)、自治医科大学附属さいたま医療センター(埼玉県)、聖路加国際病院(東京都)、東京女子医科大学東医療センター(東京都)、浜松南病院(静岡県)、藤田保健衛生大学坂文種報徳會病院(愛知県)、長崎県 上五島病院(長崎県)、金沢大学附属病院(石川県)、川崎医科大学附属病院(岡山県)、KKR札幌医療センター 斗南病院(北海道)、マサチューセッツ総合病院・ハーバードメディカルスクール(アメリカ合衆国 マサチューセッツ州) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://www.nature.com/ajg/journal/vaop/ncurrent/pdf/ajg2016478a.pdf |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000002534 |